|Title||The Genomic Consultation Service: A clinical service designed to improve patient selection for genome-wide sequencing in British Columbia.|
|Publication Type||Journal Article|
|Year of Publication||2018|
|Authors||Elliott AM, Souich Cdu, Adam S, Dragojlovic N, van Karnebeek C, Nelson TN, Lehman A, Lynd LD, Friedman JM|
|Corporate Authors||CAUSES Study|
|Journal||Mol Genet Genomic Med|
BACKGROUND: Access to clinical diagnostic genome-wide sequencing (GWS; exome or whole genome sequencing) is limited in British Columbia. The establishment of a translational research initiative (CAUSES) to provide diagnostic genome-wide sequencing for 500 children necessitated the development of a genomic consultation service, a clinical service established to provide consultation for physicians considering GWS for their pediatric patients throughout British Columbia. The Genomic Consultation Service provides patient-specific genomic advice that may include: GWS, multi-gene panel, single gene test, referral to medical genetics for clinical evaluation, or no genetic testing. Here, we describe and evaluate this service.
METHODS: We analyzed referral patterns, patient demographics, clinical indications, and genomic advice provided during the first year of this service. Comparison of outcomes from the first 6 months versus the last 6 months was performed.
RESULTS: A total of 407 referrals (238 males and 169 females [p = .0006]) were processed in the first year. Only children were eligible for referral and average patient age was 8 years. Medical genetics was the most frequent referring discipline, followed by biochemical disease and pediatric neurology, respectively. Most patients (68%) had syndromic intellectual disability. There was a significant difference in the frequency of referrals not appropriate for GWS in the first versus the second 6 months of the service (75/220 vs. 42/187; p = .01) suggesting increasing awareness of testing criteria by referring physicians.
CONCLUSION: This triage service is utilized throughout the province and appears to be an important factor in the high diagnostic rate (>40%) achieved in our GWS program.
|Alternate Journal||Mol Genet Genomic Med|
|PubMed Central ID||PMC6081221|